Retrieved 14 May 2022, from A Phase III, Multicentre, Double-Blind, Randomised, Placebo-Controlled Study to Confirm the Safety and Efficacy of Subcutaneous Bioresorbable Afamelanotide Implants in Patients with Erythropoietic Protoporphyria (EPP)
Such an imbalance is responsible for severe damage to essential biomolecules, such as lipids (lipid peroxidation), proteins (oxidation and inactivation), and DNA (strand breakage and mutations), which is associated with the pathogenesis of numerous diseases, including cancer, neurodegenerative diseases, cardiovascular diseases, and the aging process [28]
For more detailed instructions, please consult your healthcare provider or pharmacist
We are based in Bebington and could be easily accessed from surrounding areas including Wirral, New Ferry, Birkenhead, Bromborough, Wallasey and Heswall
Schedule a no-cost video chat with one of our Providers
2008 Jun;87(6):1899-1905